Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Suneel D. Kamath
Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit From Olaparib
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Will Chinese Ovarian Cancer Patients Benefit From Knowing the BRCA2 Mutation Status?
Chinese Journal of Cancer
Clinical Predictors of Durable Clinical Benefit of Pembrolizumab Therapy in Veterans With Metastatic Non–Small Cell Lung Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Clinical Outcome of Treatment of Metastatic Non-Small Cell Lung Cancer in Patients Harboring Uncommon EGFR Mutation
BMC Cancer
Cancer Research
Oncology
Genetics
Durable Hypogammaglobulinemia Associated With Thymoma (Good Syndrome)
Internal Medicine
Internal Medicine
Medicine
Durable Molecular Remission in a Lymphoid BP-CML Patient Harboring T315I Mutation Treated With Anti-Cd19 CAR-T Therapy
OncoTargets and Therapy
Oncology
Pharmacology
Germline BRCA1 and BRCA2 Deleterious Mutations and Variants of Unknown Clinical Significance Associated With Breast/Ovarian Cancer: A Report From North India
Cancer Management and Research
Oncology
Health-Related Quality of Life in Patients With a Germline BRCA Mutation and Metastatic Pancreatic Cancer Receiving Maintenance Olaparib
Annals of Oncology
Medicine
Oncology
Hematology
Pcn149 - Cost-Effectiveness of Brca1/2 Mutation Profiling to Target Olaparib Use in Patients With Metastatic Breast Cancer in Japan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Therapeutic Response of Metastatic Colorectal Cancer Harboring aKRASMissense Mutation After Combination Chemotherapy With the EGFR Inhibitor Panitumumab
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
